[
    [
        {
            "time": "2021-03-31",
            "original_text": "广药集团旗下上市公司白云山取得首季开门红，创新驱动大南药板块转型升级",
            "features": {
                "keywords": [
                    "白云山",
                    "开门红",
                    "创新驱动",
                    "大南药",
                    "转型"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "广药集团旗下上市公司白云山取得首季开门红，创新驱动大南药板块转型升级",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-01",
            "original_text": "快讯 | 白云山发布2021年一季报：销售费用与净利润同增，公司启动分拆医药公司到港交所上市",
            "features": {
                "keywords": [
                    "白云山",
                    "一季报",
                    "销售费用",
                    "净利润",
                    "分拆",
                    "港交所"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "快讯 | 白云山发布2021年一季报：销售费用与净利润同增，公司启动分拆医药公司到港交所上市",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-02",
            "original_text": "恒指收涨0.45%，生物医药、物业管理股领涨",
            "features": {
                "keywords": [
                    "恒指",
                    "生物医药",
                    "物业管理",
                    "领涨"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "物业"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒指收涨0.45%，生物医药、物业管理股领涨",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-03",
            "original_text": "首季开门红广药白云山净利润大增37%",
            "features": {
                "keywords": [
                    "白云山",
                    "开门红",
                    "净利润",
                    "增长37%"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "首季开门红广药白云山净利润大增37%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-04",
            "original_text": "【异动股】白云山(00874-HK)涨6.43%",
            "features": {
                "keywords": [
                    "白云山",
                    "异动股",
                    "涨6.43%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【异动股】白云山(00874-HK)涨6.43%",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-05",
            "original_text": "广药白云山2021年一季度营收200亿元 净利16.27亿元",
            "features": {
                "keywords": [
                    "白云山",
                    "营收200亿",
                    "净利16.27亿"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "广药白云山2021年一季度营收200亿元 净利16.27亿元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-06",
            "original_text": "白云山取得“开门红” 一季度营收突破200亿元净利润增长37%",
            "features": {
                "keywords": [
                    "白云山",
                    "开门红",
                    "营收200亿",
                    "净利润增长37%"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白云山取得“开门红” 一季度营收突破200亿元净利润增长37%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-07",
            "original_text": "港股抗疫概念板块走强，开拓药业涨7.73%，白云山涨5.64%，京东健康涨超5%，复星医药涨3.5%",
            "features": {
                "keywords": [
                    "抗疫概念",
                    "白云山",
                    "涨5.64%",
                    "京东健康",
                    "复星医药"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股抗疫概念板块走强，开拓药业涨7.73%，白云山涨5.64%，京东健康涨超5%，复星医药涨3.5%",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-08",
            "original_text": "广药集团旗下上市公司白云山净利润大增37%、现金流净增50.8亿元",
            "features": {
                "keywords": [
                    "白云山",
                    "净利润大增37%",
                    "现金流净增50.8亿"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "广药集团旗下上市公司白云山净利润大增37%、现金流净增50.8亿元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-09",
            "original_text": "白云山急升逾9% 一季度归母纯利同比增37%至16.27亿元",
            "features": {
                "keywords": [
                    "白云山",
                    "急升9%",
                    "归母纯利",
                    "增长37%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白云山急升逾9% 一季度归母纯利同比增37%至16.27亿元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 10,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]